|
C2ORF44 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.425400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.497610E-02 |
| Normal-vs-Stage2 |
9.250600E-01 |
| Normal-vs-Stage3 |
6.417200E-01 |
| Normal-vs-Stage4 |
8.473000E-01 |
| Stage1-vs-Stage2 |
6.251700E-02 |
| Stage1-vs-Stage3 |
2.720700E-03 |
| Stage1-vs-Stage4 |
8.535100E-03 |
| Stage2-vs-Stage3 |
7.800400E-01 |
| Stage2-vs-Stage4 |
9.600800E-01 |
| Stage3-vs-Stage4 |
7.779600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.157800E-01 |
| Normal-vs-AfricanAmerican |
4.247600E-01 |
| Normal-vs-Asian |
3.923500E-03 |
| Caucasian-vs-AfricanAmerican |
7.898600E-01 |
| Caucasian-vs-Asian |
3.394400E-02 |
| AfricanAmerican-vs-Asian |
8.941700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.457800E-01 |
| Normal-vs-Female |
1.933190E-01 |
| Male-vs-Female |
5.816200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.466000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.690300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.915200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.384800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.116800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.509000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.264000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.168960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.247370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.151400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.178440E-03 |
| Normal-vs-Grade 2 |
1.155740E-02 |
| Normal-vs-Grade 3 |
9.703000E-01 |
| Normal-vs-Grade 4 |
2.286000E-01 |
| Grade 1-vs-Grade 2 |
1.136050E-01 |
| Grade 1-vs-Grade 3 |
2.660900E-03 |
| Grade 1-vs-Grade 4 |
3.848800E-04 |
| Grade 2-vs-Grade 3 |
2.520000E-03 |
| Grade 2-vs-Grade 4 |
2.588500E-04 |
| Grade 3-vs-Grade 4 |
1.645600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.782600E-03 |
| Normal-vs-ccB subtype |
7.104400E-01 |
| ccA subtype-vs-ccB subtype |
2.248000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.275200E-01 |
| Normal-vs-N1 |
5.315600E-01 |
| N0-vs-N1 |
7.334200E-01 |
|
|
